NEWARK, DE / ACCESSWIRE / May 18, 2023 / As per the FMI survey, the net valuation of the USA Animal Model Market reached US$ 947.3 Million in the year 2022. The FMI market analysis report further predicts the overall market to progress at an average annual growth rate of 4.3% through 2033. By 2033, the USA Animal Model market is projected to reach over US$ 1,487.9 Million, with rising healthcare spending, and customized pharmaceutical consumption.
Continuous advancements in the field of customized medicines have created a lot of opportunities. These are going to help in treating various diseases and allowed for the creation of patient-centric Animal Models. These further promoted the use of animal-based models in the research and development of precision medicines around the world.
For Details on Vendors and Their Offerings - Request your Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14527
Pharmaceutical and biopharmaceutical companies accelerated their use of Animal Models during the pandemic years to develop diagnostic tools, vaccines, and antiviral medications. Many notable global biomedicine research institutes collaborated with Animal Model companies based in the United States strengthening their sales during this period.
The United States is seeing a sharp rise in the creation and release of customized medical solutions. This rise may be ascribed to various problems with the unfavourable side effects of some medications. Demand for Animal Model-based research is being boosted by federal government programs aimed at accelerating the implementation of customized medicine in the nation. In the past, the United States government launched the Precision Medicine Initiative to understand cancer genetics and develop potent treatments for chronic illnesses.
Key Takeaways:
- Back in the year 2017, the demand for Animal Models in the United States, in terms of value, was nearly 818.7 Million.
- Over the next ten years, the Animal Model market in the United States is projected to witness an absolute growth of US$ 540.6 Million.
- Based on different species types, mice are the most preferred models and acquire a market share of 61.03% in the United States.
- Among the different end-user verticals, most of the demand for animal-based models comes from academic and research institutes. This segment generated a revenue of around US$ 352.5 Million in 2022, which was figured out to be 37.21% of the market.
Competitive Landscape:
Key firms in the market are using strategic formulations including forward integration, global expansion, and research alliances to maximize their revenue share and foster business growth. As there are many established participants in the supply of Animal Models, the overall USA market is fairly distributed and fragmented. However, the market is somewhat consolidated by large investments made by the DARPA and National Institutes of Health in the last few years.
Recent Developments:
- The Jackson Laboratory Inc. reported in February 2020 that a specific hACE2 genetically altered mouse model was available to aid COVID-19 research. This change presented fresh chances to create cutting-edge transgenic mice study models for the best results in clinical studies.
- Charles River Laboratories Inc. and genOway, which is a biotechnology research company that creates transgenic research models, announced their alliance in May 2018. 2000 Ready-to-Use Knockout Mouse Models were to be made available through this agreement for in vivo research projects. The firm was able to strengthen its market position and obtain an edge over others after this strategic relationship.
Key Players:
- Charles River Laboratories
- The Jackson Laboratory
- Taconic Biosciences, Inc.
- Genoway
- Envigo (Inotiv, Inc.)
- Marshall BioResources
- Janvier Labs
- Applied stem cells
- Biocytogen
- Others
Ask More About This Market's Geographical Distribution Along With a Detailed Analysis of the Top Regions @ https://www.futuremarketinsights.com/ask-question/rep-gb-14527
Key Segments Covered:
By Species:
- Mice
- Rats
- Fish
- Birds
- Cattles
- Pigs
- Amphibians
- Guinea Pigs
- Dogs
- Cats
- Rabbits
- Monkeys
- Sheep
- Hamsters
- Other Animals
By Technology:
- Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
- Microinjection
- Nuclear Transfer
- Other Technologies
By Application:
- Research & Development
- Infectious Disease
- Immunological Diseases
- Cancer
- Cardiovascular Diseases
- Diabetes
- Genetic Diseases
- Neurological Diseases
- Obesity
- NAFLD or NASH
- Renal disease
- Diabetic eye disease
- Fibrosis
- Micro-biome
- Other Research and Developments
- Production and Quality Control
- Academics
- Preclinical Applications
- Infectious Disease
- Immunological Diseases
- Cancer
- Cardiovascular Diseases
- Diabetes
- Genetic Diseases
- Neurological Diseases
- Obesity
- NAFLD/NASH
- Renal disease
- Diabetic eye disease
- Fibrosis
- Micro-biome
- Other Preclinical Applications
- Other Applications
By Use:
- Human
- Veterinary
By End-user Verticals:
- Companies
- Pharmaceutical
- Biotechnology
- Cosmetics
- Other Companies
- Organizations
- Government
- Non-government
- Academic and Research Institutes
- Contract Research Organizations (CRO)
Request Methodology @ https://www.futuremarketinsights.com/request-report-methodology/rep-gb-14527
Table of Content (ToC):
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and Their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyers
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter's Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Species
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Species, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Species, 2023 to 2033
5.3.1. Mouse
5.3.2. Rat
5.3.3. Zebrafish
5.3.4. Rabbit
5.3.5. Guinea pig
5.3.6. Others
5.4. Y-o-Y Growth Trend Analysis By Species, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Species, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Therapeutics
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Therapeutics, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Therapeutics, 2023 to 2033
6.3.1. Oncology
6.3.2. Cardiovascular diseases
6.3.3. Neurological disorders
6.3.4. Immunological disorders
6.3.5. Genetic disorders
6.3.6. Others
6.4. Y-o-Y Growth Trend Analysis By Therapeutics, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Therapeutics, 2023 to 2033
Buy Now to Gain Access to Detailed Information About Each Segment and Identify Key Trends, Drivers, and Challenges in the Market @ https://www.futuremarketinsights.com/checkout/14527
Have a Look at Related Reports of the Healthcare domain:
Dental Laboratories Market Size: The global dental laboratories market is set to witness substantial growth at a CAGR of about 5.6% from 2022 to 2032. The dental lab market size reached a valuation of around US$ 29.24 Billion in 2021.
Vascular Patches Market Share: Global demand for vascular patches is set to grow by 5.8% from 2021 to 2031, with an estimated market value of around US$ 136.9 Million as of 2021.
HIV Diagnostics Market Growth: The HIV diagnostics market is anticipated to record a steady CAGR of 7.9% during the period 2022 to 2032.
Hospital Supplies Market Analysis: The global demand for hospital supplies is expected to increase at 3.7% CAGR over the forecast period from 2022 to 2032.
Hemodialys and Peritoneal Dialysis Market Demand: The hemodialys and peritoneal dialysis market are anticipated to have a significant CAGR of 6.1% during the period of 2022 to 2032.
Interventional Cardiology Devices Market Trends: Global demand for interventional cardiology devices is anticipated to record a CAGR of 8.4% during the forecast period (2022 to 2032).
Robotic Wheelchair Market Forecast: The global demand for the robotic wheelchair market is set to witness growth at 11.5% CAGR from 2022 to 2032, surpassing US$ 127.1 Million in 2022.
Depression Treatment Market Overview: The global depression treatment market is set to exceed US$ 10.1 Billion in 2022, and expand3 at a CAGR of 5.2% to reach US$ 16.8 Billion by 2032.
Dental Compressors Market Outlook: The dental compressors market is registering a valuation of US$ 378.75 Million in 2023. The market is likely to rise to US$ 529.12 Million by 2033. The market is expected to secure a CAGR of 3.4% during the forecast period.
DNA Diagnostics Market Status and Prospects: Owing to the growing support from various governmental organizations, the market is likely to propel to US$ 51.5 Billion by 2032.
About Future Market Insights (FMI):
Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10 years.
Contact Us:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: [email protected]
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs
SOURCE: Future Market Insights, Inc.